Back to
CITADEL ADVISORS LLC
CTMX30 quarters
Position history for
CITADEL ADVISORS LLC's holdings in CYTOMX THERAPEUTICS INC.
CITADEL ADVISORS LLC holds 3.1M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $11.7M as of 2026-Q2. The position was decreased (-42.5% shares). CTMX represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$11.7M
Current Shares
3.1M
Total Value Change
+$11.3M
Total Shares Change
+3.1M
Quarter-by-Quarter History
Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS